Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care providers. It leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon’s name and by developing and commercializing medical products for other medical companies under development and license contracts. It provides a range of specialized medical devices, medical dressings and advanced medical technology designed for infection prevention, complex wound closure and perioperative care. Its perioperative care solutions provide antimicrobial protection of pre-operative skin, through postoperative incision care to scar prophylaxis.


TSXV:COV - Post by User

Bullboard Posts
Comment by zenvestingon Feb 12, 2018 12:21am
100 Views
Post# 27542795

RE:Q1 results out on Monday

RE:Q1 results out on Monday Don't think this buyer could find much motivation in last quarters numbers, but do believe there is billion dollar potential in this company's technology pipeline for medical device coatings and skin tissue repair technologies.....although that pipeline is very dark to the average investor who doesn't attend annual meetings or the few select investor conferences the company presents at. For instance, Google "skin cells crawl together" for a little news piece the University of Toronto published about their joint R&D that the company has never mentioned on their own. The company has been shopping around for M&A candidates, maybe one of these companies likes what they saw? Truthfully, as a long-term holder here, I'm a bit concerned the Q1 release may spur selling from those who only value a stock based on current financial results.....where as I believe it might deserve a forward looking valuation like US-based companies MDXG or MDWD.
Bullboard Posts